Answers are grounded in this paper and cite their sources.
Novel probe efficiently detects and removes apoptotic cells in high-throughput settings, indicating potential for biomarker discovery.
Description Phosphatidylserine (PS) exposure on the outer leaflet of cell membranes is a hallmark of apoptotic cells and plays a critical role in immune clearance and signaling. As an immunosuppressive signal, externalized PS is often exploited by cancer cells and pathogens to evade detection, making it a key target for research into apoptosis and PS-based therapeutic strategies. BioLegend has successfully commercialized Apotracker™ Green, a uniquely designed peptide that incorporates BODIPY. Apotracker Green specifically binds to PS in a calcium-independent manner, offering enhanced versatility over traditional PS detection methods. Building on this innovation, we have developed Apotracker tag, a modified peptide-based probe that retains high-affinity PS binding while allowing flexible conjugation with various tags. Here, we demonstrated that Apotracker tag can rapidly identify apoptotic and dead cells in under 5 minutes without the need for buffer changes or washing steps. Its efficacy is demonstrated across multiple applications, including multicolor flow cytometry, cell sorting, multiplex imaging, fluorescence-based cell counting, and high-throughput screening. Additionally, when combined with magnetic beads, Apotracker tag can be used to efficiently remove apoptotic and dead cells and enrich PS-positive extracellular vesicles. These multiplexed applications in high-throughput settings hold great potential for drug screening and biomarker discovery.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: